These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27281861)

  • 1. Genitourinary Syndrome Of Menopause and Vaginal Estrogen Use.
    Steele NM; Ledbetter CA; Bernier F
    Urol Nurs; 2016; 36(2):59-65, 71. PubMed ID: 27281861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol vaginal inserts (Imvexxy): effective in genitourinary syndrome of menopause without increasing systemic estrogen levels.
    Paton DM
    Drugs Today (Barc); 2018 Nov; 54(11):667-677. PubMed ID: 30539166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genitourinary syndrome of menopause in breast cancer survivors:Treatments are available.
    Moreno AC; Sikka SK; Thacker HL
    Cleve Clin J Med; 2018 Oct; 85(10):760-766. PubMed ID: 30289755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal estrogen and mammogram results: case series and review of literature on treatment of genitourinary syndrome of menopause (GSM) in breast cancer survivors.
    Zuo SW; Wu H; Shen W
    Menopause; 2018 Jul; 25(7):828-836. PubMed ID: 29533365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?
    Trinkaus M; Chin S; Wolfman W; Simmons C; Clemons M
    Oncologist; 2008 Mar; 13(3):222-31. PubMed ID: 18378532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.
    Simon JA; Goldstein I; Kim NN; Davis SR; Kellogg-Spadt S; Lowenstein L; Pinkerton JV; Stuenkel CA; Traish AM; Archer DF; Bachmann G; Goldstein AT; Nappi RE; Vignozzi L
    Menopause; 2018 Jul; 25(7):837-847. PubMed ID: 29870471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local hormone therapy for genitourinary syndrome of menopause in breast cancer patients: is it safe?
    Oyarzún MFG; Castelo-Branco C
    Gynecol Endocrinol; 2017 Jun; 33(6):418-420. PubMed ID: 28277141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urogenital system and the menopause.
    Calleja-Agius J; Brincat MP
    Climacteric; 2015; 18 Suppl 1():18-22. PubMed ID: 26366796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not time to abandon use of local vaginal hormone therapies.
    Pinkerton JV; Kaunitz AM; Manson JE
    Menopause; 2018 Aug; 25(8):855-858. PubMed ID: 29894370
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.
    Crean-Tate KK; Faubion SS; Pederson HJ; Vencill JA; Batur P
    Am J Obstet Gynecol; 2020 Feb; 222(2):103-113. PubMed ID: 31473229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Vaginal Estrogen Therapy for Genitourinary Syndrome of Menopause in Women With a History of Breast Cancer.
    Agrawal P; Singh SM; Able C; Dumas K; Kohn J; Kohn TP; Clifton M
    Obstet Gynecol; 2023 Sep; 142(3):660-668. PubMed ID: 37535961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genitourinary syndrome of menopause: Common problem, effective treatments.
    Phillips NA; Bachmann GA
    Cleve Clin J Med; 2018 May; 85(5):390-398. PubMed ID: 29733783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the genitourinary syndrome of menopause.
    Palacios S; Mejía A; Neyro JL
    Climacteric; 2015; 18 Suppl 1():23-9. PubMed ID: 26366797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal Estrogen-What a Urologist Should Know.
    Escobar C; Rosenblum N
    Urology; 2021 May; 151():37-43. PubMed ID: 32504683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens and the lower urinary tract.
    Robinson D; Cardozo L
    Neurourol Urodyn; 2011 Jun; 30(5):754-7. PubMed ID: 21661025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause.
    Kagan R; Kellogg-Spadt S; Parish SJ
    Drugs Aging; 2019 Oct; 36(10):897-908. PubMed ID: 31452067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer Name, Newer Treatments: The Genitourinary Syndrome of Menopause.
    Vegunta S; Files J; Kling JM
    J Womens Health (Larchmt); 2019 Jul; 28(7):897-899. PubMed ID: 31334693
    [No Abstract]   [Full Text] [Related]  

  • 18. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause.
    Biehl C; Plotsker O; Mirkin S
    Menopause; 2019 Apr; 26(4):431-453. PubMed ID: 30363010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause.
    Buck ES; Lukas VA; Rubin RS
    Urology; 2021 May; 151():31-36. PubMed ID: 32533967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal estrogen in the treatment of genitourinary syndrome of menopause and risk of endometrial cancer: an assessment of recent studies provides reassurance.
    Pinkerton JV; Kaunitz AM; Manson JE
    Menopause; 2017 Dec; 24(12):1329-1332. PubMed ID: 29040220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.